RobertLawrenceFindlingMDMBA

Child & Adolescent Psychiatry

Chair, Department of Psychiatry, Virginia Commonwealth University

Dr. Findling is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
501 N. 2nd Street, 4th Floor
PO Box 980308
Richmond, VA 23298
Phone+1 804-828-9156

London School of Economics, NYU Stern, HEC ParisMBA, Business Administration, 2009 - 2011
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalFellowship, Child and Adolescent Psychiatry, 1991 - 1992
Icahn School of Medicine at Mount Sinai/Kravis Children'sResidency, Pediatrics, 1987 - 1990
Virginia Commonwealth University School of MedicineClass of 1987

PubMed

1 citations
Extension and Further Replication of the Reliability, Criterion Validity, and Treatment Sensitivity of the PANSS10 and PANSS20 for Pediatric Trials.
Joshua A Langfus, Eric A Youngstrom, David Daniel, Joan Busner, Robert L Findling
Journal of Child and Adolescent Psychopharmacology. 2024-12-01
Vortioxetine in children and adolescents with major depressive disorder: 6-month and 18-month open-label, flexible-dose, long-term extension studies.
Melissa P DelBello, Robert L Findling, Michael Huss, Oscar Necking, Maria L Petersen
European Child & Adolescent Psychiatry. 2024-09-06
1 citations
Parental perceptions of body weight and appetite in infants and toddlers with cystic fibrosis.
Sarah Ann Duck, Elena Jansen, Afroditi Papantoni, Aerial Sheltry, Daphne Koinis-Mitchell
Appetite. 2024-07-01

The Workforce Shortage of Child and Adolescent Psychiatrists: Is It Time for a Different Approach?April 2018

Longitudinal Assessment Of Manic SymptomsNational Institute Of Mental Health2005–2012
Functional Comparison Of Induced Pluripotent Stem Cell-Derived Oligodendrocytes INational Institute Of Mental Health2011
3/4-Stimulant And Risperidone For Youth With Severe Physical AggressionNational Institute Of Mental Health2008–2011
Functional Comparison Of Induced Pluripotent Stem Cell-Derived Oligodendrocytes INational Institute Of Mental Health2009–2010
Treatment Of Early Onset Schizophrenia Spectrum (TEOSS)National Institute Of Mental Health2001–2005
Pediatric Bipolar Collaborative Mood Stabilzer TrailNational Institute Of Mental Health2001–2003
Prosyndromal Pediatr: Families Ascertained By Parental Cases: Bipolar DisorderNational Center For Research Resources1999–2001
Familial Attent Deficit &Hyperactiv Based On Pediatric Cases:Behavior DisordersNational Center For Research Resources1999–2001
Pediatric Bipolar Collaborative Mood Stabilizer TrialNational Institute Of Mental Health2000
Pilot Study Of ST Johns Wort In Juvenile DepressionNational Institute Of Mental Health1998–1999
Paroxetine In Child And Adolescent Psychiatric DisordersNational Center For Research Resources1998–1999
Paroxetine In Childhood And Adolescent Psychiatric DisordersNational Center For Research Resources1996–1997
Risperidone In Children With Autistic DisorderNational Center For Research Resources1996

Hopkins Child Psychiatryhttp://www.hopkinsmedicine.org/psychiatry/specialty_areas/child_adolescent/
KKI Profilehttp://kennedykrieger.org/patient-care/faculty-staff
Hopkins Child Psychiatryhttp://www.hopkinsmedicine.org/psychiatry/index.html